pI: 9.3228 |
Length (AA): 1429 |
MW (Da): 170705 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 14 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
980 | 1428 | 1omw (A) | 34 | 458 | 24.00 | 0 | 1 | 0.5 | 0.11 |
1150 | 1427 | 2acx (A) | 183 | 452 | 30.00 | 0.00000000044 | 1 | 0.6 | -1.19 |
689 | 1206 | 2vkh (A) | 3 | 516 | 25.00 | 0.22 | 0.79 | 0.269591 | 0.97 |
1066 | 1428 | 4yhj (A) | 94 | 454 | 25.00 | 0 | 1 | 0.399624 | 0.66 |
1138 | 1429 | 2rku (A) | 38 | 311 | 32.00 | 0 | 1 | 0.514939 | 0.11 |
1146 | 1423 | 2bdw (A) | 5 | 271 | 25.00 | 0 | 1 | 0.449142 | -0.03 |
1281 | 1355 | 4ix3 (A) | 314 | 410 | 45.00 | 0.29 | 0.21 | 0.0405843 | 1.38 |
253 | 365 | 3na7 (A) | 63 | 174 | 26.00 | 0.48 | 0.02 | 0.379143 | -1.37 |
440 | 634 | 4uos (A) | 2 | 180 | 34.00 | 0.081 | 1 | 0.305546 | -0.14 |
508 | 697 | 4qts (A) | 33 | 215 | 37.00 | 0.6 | 0.29 | -0.0769602 | 2.24 |
1044 | 1424 | 2acx (A) | 90 | 452 | 24.00 | 0.0000000047 | 1 | 0.204081 | 0.81 |
1135 | 1426 | 2rku (A) | 38 | 311 | 32.00 | 0 | 1 | 0.514669 | 0.11 |
1196 | 1424 | 2i6l (B) | 59 | 320 | 33.00 | 0.00014 | 1 | 0.315389 | -0.1 |
1278 | 1352 | 4ix3 (A) | 314 | 410 | 45.00 | 0.29 | 0.21 | 0.0403947 | 1.38 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | early schizont, early trophozoite, late trophozoite, Oocyst, Male Gametocyte. | PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte, sporozoite, late ring, late schizont, Female Gametocyte. | Otto TD PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, Ring, Sporozoite. | Otto TD Zanghi G |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Ortholog group members (OG5_128190)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G20930 | serine/threonine-protein kinase TOUSLED |
Babesia bovis | BBOV_III008760 | protein kinase domain containing protein |
Brugia malayi | Bm1_45930 | Serine/threonine-protein kinase C07A9.3 |
Caenorhabditis elegans | CELE_C07A9.3 | Protein TLK-1, isoform B |
Cryptosporidium hominis | Chro.80144 | ENSANGP00000017360 |
Cryptosporidium hominis | Chro.80146 | hypothetical protein |
Cryptosporidium parvum | cgd8_1230 | proteine kinase |
Drosophila melanogaster | Dmel_CG34412 | Tousled-like kinase |
Echinococcus granulosus | EgrG_000784600 | serine:threonine protein kinase tousled |
Echinococcus multilocularis | EmuJ_000784600 | serine:threonine protein kinase tousled |
Homo sapiens | ENSG00000198586 | tousled-like kinase 1 |
Homo sapiens | ENSG00000146872 | tousled-like kinase 2 |
Homo sapiens | 101928451 | serine/threonine-protein kinase tousled-like 2-like |
Leishmania braziliensis | LbrM.31.3220 | protein kinase, putative |
Leishmania donovani | LdBPK_312960.1 | protein kinase, putative |
Leishmania infantum | LinJ.31.2960 | protein kinase, putative |
Leishmania major | LmjF.31.2860 | protein kinase, putative |
Leishmania mexicana | LmxM.30.2860 | protein kinase, putative |
Loa Loa (eye worm) | LOAG_04311 | TLK protein kinase |
Mus musculus | ENSMUSG00000020694 | tousled-like kinase 2 (Arabidopsis) |
Mus musculus | ENSMUSG00000041997 | tousled-like kinase 1 |
Neospora caninum | NCLIV_049660 | MGC53542 protein, related |
Oryza sativa | 4334117 | Os03g0749800 |
Plasmodium berghei | PBANKA_0901100 | serine/threonine protein kinase, putative |
Plasmodium falciparum | PF3D7_1148000 | serine/threonine protein kinase, putative |
Plasmodium knowlesi | PKNH_0945900 | serine/threonine protein kinase, putative |
Plasmodium vivax | PVX_092985 | serine/threonine protein kinase, putative |
Plasmodium yoelii | PY05975 | pKU-alpha protein kinase, putative |
Plasmodium yoelii | PY04928 | hypothetical protein |
Schistosoma japonicum | Sjp_0201380 | expressed protein |
Schistosoma japonicum | Sjp_0201370 | expressed protein |
Schistosoma mansoni | Smp_141580 | protein kinase |
Schmidtea mediterranea | mk4.000668.05 | Serine/threonine-protein kinase tousled-like 1 |
Trypanosoma brucei gambiense | Tbg972.4.5370 | protein kinase, putative |
Trypanosoma brucei gambiense | Tbg972.8.7480 | protein kinase, putative |
Trypanosoma brucei | Tb927.8.7220 | tousled-like kinase II |
Trypanosoma brucei | Tb927.4.5180 | tousled-like kinase I |
Trypanosoma congolense | TcIL3000_8_7300 | protein kinase, putative |
Trypanosoma congolense | TcIL3000_0_18290 | tousled-like kinase I |
Trypanosoma congolense | TcIL3000_0_46960 | tousled-like kinase I |
Trypanosoma cruzi | TcCLB.506419.20 | tousled-like kinase II, putative |
Trypanosoma cruzi | TcCLB.510597.9 | tousled-like kinase II, putative |
Toxoplasma gondii | TGME49_234970 | Tyrosine kinase-like (TKL) protein |
Theileria parva | TP04_0778 | hypothetical protein, conserved |
Theileria parva | TP04_0777 | hypothetical protein |
Trichomonas vaginalis | TVAG_394290 | CAMK family protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.5180 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.5180 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.5180 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.4.5180 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.8.7220 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.7220 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.7220 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.7220 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C07A9.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C07A9.3 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_0901100 | Plasmodium berghei | Essential | plasmo |
TGME49_234970 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.5
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | tousled-like kinase 1 | Compounds | References |
Homo sapiens | tousled-like kinase 2 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 29.8% | 299 aa | Compounds | References |
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 25.3% | 308 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 31.1% | 241 aa | Compounds | References |